Stock listing
BOATS:ABOS Acumen Pharmaceuticals, Inc. Stock
US listing (BOATS) of Acumen Pharmaceuticals, Inc. · home listing NASDAQ:ABOS
Follow Acumen Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ABOS
$2.29 USD -0.09 (-3.8%)
Close on Oct 29, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ABOS
- Day range
- $2.29 – $2.52 USDOct 29, 2026
- Volume
- 807,400 sharesOct 29, 2026
- Market cap
- $165.6M USDAt the close on Oct 29, 2026 · price × 72.33M shares outstanding
- 52-week range
- $1.50 – $3.60 USDLowest and highest trades, Oct 30, 2025 – Oct 29, 2026
- Traded on an average day
- $1.24M USDMedian day 430,950 shares · last 3 months, Jul 29, 2026 – Oct 29, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ABOS · Home | $2.29 USD | -0.09 (-3.8%) | 807,400 | $2.40 | $2.52 | $2.285 | $2.38 | Close on Oct 29, 2026 |
Daily closes
Last 3 months, Jul 29, 2026 – Oct 29, 2026 · NASDAQ:ABOS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.29 | -0.09 | -3.8% | $2.40 | $2.52 | $2.285 | 807,400 | |
| $2.38 | +0.12 | +5.3% | $2.28 | $2.495 | $2.257 | 1,407,800 | |
| $2.26 | -0.01 | -0.4% | $2.25 | $2.37 | $2.10 | 1,797,500 | |
| $2.27 | +0.29 | +14.6% | $2.13 | $2.42 | $1.97 | 1,646,800 | |
| $1.98 | -0.08 | -3.9% | $2.05 | $2.05 | $1.895 | 541,800 | |
| $2.06 | +0.03 | +1.5% | $2.03 | $2.14 | $2.01 | 569,500 | |
| $2.03 | +0.015 | +0.7% | $2.00 | $2.08 | $1.99 | 397,600 | |
| $2.015 | +0.245 | +13.8% | $1.78 | $2.07 | $1.764 | 784,300 | |
| $1.77 | +0.08 | +4.7% | $1.70 | $1.78 | $1.67 | 274,600 | |
| $1.69 | +0.02 | +1.2% | $1.67 | $1.715 | $1.62 | 449,300 | |
| $1.67 | -0.075 | -4.3% | $1.71 | $1.755 | $1.66 | 602,500 | |
| $1.745 | -0.07 | -3.9% | $1.81 | $1.87 | $1.71 | 619,800 | |
| $1.815 | -0.205 | -10.1% | $2.00 | $2.00 | $1.81 | 646,100 | |
| $2.02 | -0.12 | -5.6% | $2.14 | $2.14 | $2.00 | 291,500 | |
| $2.14 | +0.04 | +1.9% | $2.12 | $2.17 | $2.081 | 357,500 | |
| $2.10 | 0.00 | 0.0% | $2.09 | $2.135 | $2.02 | 505,200 | |
| $2.10 | +0.07 | +3.4% | $2.02 | $2.17 | $2.00 | 623,100 | |
| $2.03 | -0.10 | -4.7% | $2.13 | $2.14 | $2.00 | 562,900 | |
| $2.13 | +0.09 | +4.4% | $2.04 | $2.16 | $2.015 | 713,900 | |
| $2.04 | -0.03 | -1.4% | $2.10 | $2.10 | $2.015 | 580,500 | |
| $2.07 | -0.15 | -6.8% | $2.22 | $2.29 | $2.07 | 832,800 | |
| $2.22 | -0.025 | -1.1% | $2.25 | $2.45 | $2.10 | 1,482,700 | |
| $2.245 | -0.055 | -2.4% | $2.30 | $2.42 | $2.22 | 1,086,800 | |
| $2.30 | +0.06 | +2.7% | $2.22 | $2.375 | $2.19 | 856,300 | |
| $2.24 | +0.005 | +0.2% | $2.25 | $2.295 | $2.22 | 235,300 | |
| $2.235 | -0.07 | -3.0% | $2.30 | $2.34 | $2.22 | 265,800 | |
| $2.305 | -0.345 | -13.0% | $2.63 | $2.63 | $2.30 | 467,900 | |
| $2.65 | +0.06 | +2.3% | $2.61 | $2.705 | $2.60 | 567,700 | |
| $2.59 | -0.06 | -2.3% | $2.63 | $2.645 | $2.555 | 395,200 | |
| $2.65 | +0.08 | +3.1% | $2.55 | $2.67 | $2.515 | 889,900 | |
| $2.57 | -0.04 | -1.5% | $2.69 | $2.76 | $2.535 | 490,000 | |
| $2.61 | -0.28 | -9.7% | $2.92 | $2.95 | $2.59 | 369,000 | |
| $2.89 | +0.10 | +3.6% | $2.77 | $2.90 | $2.69 | 359,300 | |
| $2.79 | -0.13 | -4.5% | $2.91 | $3.015 | $2.78 | 394,200 | |
| $2.92 | +0.06 | +2.1% | $2.93 | $2.985 | $2.84 | 318,200 | |
| $2.86 | +0.01 | +0.4% | $2.79 | $2.90 | $2.73 | 467,800 | |
| $2.85 | -0.31 | -9.8% | $3.14 | $3.16 | $2.84 | 369,200 | |
| $3.16 | -0.02 | -0.6% | $3.14 | $3.29 | $3.075 | 358,100 | |
| $3.18 | +0.09 | +2.9% | $3.07 | $3.23 | $3.03 | 315,400 | |
| $3.09 | -0.01 | -0.3% | $3.13 | $3.165 | $3.05 | 452,300 | |
| $3.10 | +0.18 | +6.2% | $2.93 | $3.125 | $2.93 | 247,300 | |
| $2.92 | +0.07 | +2.5% | $2.80 | $2.95 | $2.80 | 188,900 | |
| $2.85 | -0.07 | -2.4% | $2.90 | $2.92 | $2.76 | 244,200 | |
| $2.92 | -0.11 | -3.6% | $3.02 | $3.02 | $2.885 | 305,800 | |
| $3.03 | +0.04 | +1.3% | $2.98 | $3.17 | $2.98 | 270,800 | |
| $2.99 | -0.11 | -3.5% | $3.09 | $3.09 | $2.915 | 235,000 | |
| $3.10 | +0.025 | +0.8% | $3.09 | $3.169 | $3.04 | 300,700 | |
| $3.075 | -0.085 | -2.7% | $3.17 | $3.17 | $3.04 | 276,000 | |
| $3.16 | -0.03 | -0.9% | $3.21 | $3.34 | $3.135 | 715,800 | |
| $3.19 | +0.04 | +1.3% | $3.12 | $3.245 | $3.01 | 599,700 | |
| $3.15 | +0.41 | +15.0% | $2.79 | $3.17 | $2.79 | 617,800 | |
| $2.74 | +0.08 | +3.0% | $2.66 | $2.79 | $2.636 | 309,400 | |
| $2.66 | -0.01 | -0.4% | $2.66 | $2.74 | $2.62 | 412,800 | |
| $2.67 | +0.12 | +4.7% | $2.51 | $2.695 | $2.45 | 526,700 | |
| $2.55 | +0.04 | +1.6% | $2.50 | $2.55 | $2.39 | 449,100 | |
| $2.51 | +0.04 | +1.6% | $2.41 | $2.59 | $2.40 | 487,100 | |
| $2.47 | +0.04 | +1.6% | $2.44 | $2.50 | $2.42 | 204,600 | |
| $2.43 | -0.01 | -0.4% | $2.41 | $2.45 | $2.37 | 194,400 | |
| $2.44 | +0.16 | +7.0% | $2.29 | $2.44 | $2.29 | 256,800 | |
| $2.28 | +0.04 | +1.8% | $2.24 | $2.34 | $2.23 | 228,200 | |
| $2.24 | 0.00 | 0.0% | $2.26 | $2.295 | $2.22 | 298,100 | |
| $2.24 | +0.06 | +2.8% | $2.18 | $2.27 | $2.18 | 283,400 | |
| $2.18 | +0.03 | +1.4% | $2.17 | $2.21 | $2.11 | 227,300 | |
| $2.15 | -0.02 | -0.9% | $2.21 | $2.345 | $2.12 | 263,100 | |
| $2.17 | +0.06 | +2.8% | $2.12 | $2.19 | $2.10 | 333,400 | |
| $2.11 | -0.17 | -7.5% | $2.29 | $2.31 | $2.095 | 483,000 |
- Ticker
- BOATS:ABOS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint
Latest earnings call · Oct 26, 2026
Acumen Pharmaceuticals (NASDAQ:ABOS) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 26, 2026
Investor Presentation (October 2026)
Investor deck · 49 slides
Calls
Replays
Acumen Pharmaceuticals (NASDAQ:ABOS) Q3 2026 Earnings Call
Mon, Oct 26, 2026 · 8:00 AM ET
Watch TranscriptAcumen Pharmaceuticals (NASDAQ:ABOS) Q2 2026 Earnings Call
Wed, Aug 12, 2026 · 8:00 AM ET
Watch TranscriptAcumen Pharmaceuticals (NASDAQ:ABOS) Q1 2026 Earnings Call
Tue, May 12, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights
Oct 26, 2026
Closed $2.27 (+14.6%) on Oct 26, 2026
Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Oct 22, 2026
Closed $2.06 (+1.5%) on Oct 22, 2026
Acumen Pharmaceuticals to Report Third Quarter Financial Results on October 26, 2026
Oct 19, 2026
Closed $2.02 (+13.8%) on Oct 20, 2026
Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026
Sep 10, 2026
Closed $2.92 (+2.1%) on Sep 11, 2026
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
Aug 12, 2026
Closed $2.51 (+1.6%) on Aug 12, 2026
Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026
Aug 5, 2026
Closed $2.28 (+1.8%) on Aug 6, 2026
Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026
Jul 15, 2026
Closed $2.22 (-12.3%) on Jul 15, 2026
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
Jun 16, 2026
Closed $2.29 (-2.1%) on Jun 16, 2026
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
May 12, 2026
Closed $2.48 (-3.5%) on May 12, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 49 slides · Oct 26, 2026
Investor Day (September 2026)
Investor day · 59 slides · September 2026
Q2 2026 Earnings Presentation
Earnings · 58 slides · Aug 12, 2026
AAIC 2026
Conference · 12 slides · Jul 12, 2026
Acumen Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 83 in all · newest Oct 30, 2026 · oldest 2021
- Calls
- 20 calls with a replay · 20 with a transcript · latest Oct 26, 2026
- Decks
- 45 decks · latest Oct 26, 2026
Where Acumen Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ABOS · Home listing | NASDAQ | United States | USD |
| BOATS:ABOS · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Acumen Pharmaceuticals, Inc.